JWN
53
-2
KO
34
-2
MU
39
-3
PSX
32
-2
ORLY
61
-3
ORCL
62
-3
FDX
31
-2
URI
65
-3
DNB
50
-4
BAX
45
-2
JBHT
56
-2
RRC
50
7
EQT
34
3
EQIX
72
8
WHR
50
-3
KMX
52
2
EQR
62
3
DRI
54
9
ES
63
5
BEN
33
-3
JWN
53
-2
KO
34
-2
MU
39
-3
PSX
32
-2
ORLY
61
-3
ORCL
62
-3
FDX
31
-2
URI
65
-3
DNB
50
-4
BAX
45
-2
JBHT
56
-2
RRC
50
7
EQT
34
3
EQIX
72
8
WHR
50
-3
KMX
52
2
EQR
62
3
DRI
54
9
ES
63
5
BEN
33
-3
Financhill
Back

Fate Therapeutics Quote, Financials, Valuation and Earnings

AI DIVIDENDS: No. 1 Way to Collect Passive Income

Click here to get it for free.
Sell
34

FATE
Fate Therapeutics

Last Price:
2.81
Seasonality Move:
31.52%

7 Day Trial

ALL ACCESS PASS

$ 7

The truth about AI stocks (must see)

Learn the names of all 10 stocks here. FREE.

Fate Therapeutics Price Quote

$2.81
-0.22 (-7.26%)
(Updated: October 24, 2024 at 6:25 PM ET)

Fate Therapeutics Key Stats

Sell
34
Fate Therapeutics (FATE) is a Sell
Day range:
$3.00 - $3.21
52-week range:
$1.63 - $8.83
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
26.92
P/B ratio:
0.92%
Volume:
1.1M
Avg. volume:
1.1M
1-year change:
68.33%
Market cap:
$363.3M
Revenue:
$63.5M
EPS:
$-1.71

How Much Does Fate Therapeutics Make?

Is Fate Therapeutics Growing As A Company?

  • What Is Fate Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 6.26%
  • What Is Fate Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Fate Therapeutics Stock Price Performance

  • Did Fate Therapeutics Stock Go Up Last Month?
    Fate Therapeutics share price went down by -16.76% last month
  • Did FATE's Share Price Rise Over The Last Year?
    FATE share price rose by 68.33% over the past 1 year

What Is Fate Therapeutics 52-Week High & Low?

Fate Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Fate Therapeutics?

  • How Much Debt Does Fate Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Fate Therapeutics Have?
    Cash and short term investments quarterly total is $304.9M
  • What Is Fate Therapeutics’s Book Value Per Share?
    Book value per share is 3.49

Is Fate Therapeutics Cash Flow Positive?

  • What Is FATE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$140.6M
  • What Is Fate Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $96.6M
  • What Is Fate Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $34.1M

Fate Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    FATE return on invested capital is -43.24%
  • What Is Fate Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -32.14%
  • What Is FATE Return On Equity?
    ROE is a measure of profitability and is -43.24%

Fate Therapeutics Earnings Date & Stock Price

Fate Therapeutics Competitors

  • Who Are Fate Therapeutics's Competitors?
    Below is a list of companies who compete with Fate Therapeutics or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Fate Therapeutics Dividend Yield

Fate Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 27.23%
Revenue: 625.83% 337.45%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 11
Sell Recommendations: 0
Price Target: 6.46
Upside from Last Price: 113.15%

Major Shareholders

  • How many FATE shares are owned by institutional investors?
    154.3M FATE shares are owned by institutional investors
  • How many FATE shares are owned by insiders?
    2.3M FATE shares are owned by insiders